Glick, Brad, Edward Lain, Tina Lin, and Robert Israel. “Efficacy of Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP/TAZ and Oral Treatment (Apremilast)”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S30. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/757.